These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 26202064)

  • 1. Quality-by-Design II: Application of Quantitative Risk Analysis to the Formulation of Ciprofloxacin Tablets.
    Claycamp HG; Kona R; Fahmy R; Hoag SW
    AAPS PharmSciTech; 2016 Apr; 17(2):233-44. PubMed ID: 26202064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality by design I: Application of failure mode effect analysis (FMEA) and Plackett-Burman design of experiments in the identification of "main factors" in the formulation and process design space for roller-compacted ciprofloxacin hydrochloride immediate-release tablets.
    Fahmy R; Kona R; Dandu R; Xie W; Claycamp G; Hoag SW
    AAPS PharmSciTech; 2012 Dec; 13(4):1243-54. PubMed ID: 22993122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality by design approach for formulation development: a case study of dispersible tablets.
    Charoo NA; Shamsher AA; Zidan AS; Rahman Z
    Int J Pharm; 2012 Feb; 423(2):167-78. PubMed ID: 22209997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated Application of Quality-by-Design Principles to Drug Product Development: A Case Study of Brivanib Alaninate Film-Coated Tablets.
    Badawy SI; Narang AS; LaMarche KR; Subramanian GA; Varia SA; Lin J; Stevens T; Shah PA
    J Pharm Sci; 2016 Jan; 105(1):168-81. PubMed ID: 26852852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematical approach of formulation and process development using roller compaction.
    Teng Y; Qiu Z; Wen H
    Eur J Pharm Biopharm; 2009 Oct; 73(2):219-29. PubMed ID: 19406236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. System-wide hybrid MPC-PID control of a continuous pharmaceutical tablet manufacturing process via direct compaction.
    Singh R; Ierapetritou M; Ramachandran R
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1164-82. PubMed ID: 23523542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimization of a pharmaceutical tablet formulation based on a design space approach and using vibrational spectroscopy as PAT tool.
    Chavez PF; Lebrun P; Sacré PY; De Bleye C; Netchacovitch L; Cuypers S; Mantanus J; Motte H; Schubert M; Evrard B; Hubert P; Ziemons E
    Int J Pharm; 2015; 486(1-2):13-20. PubMed ID: 25791761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using Manufacturing Design Space Concepts for Stability Risk Assessment-Gabapentin NIPTE/FDA Case Study.
    Stamatis SD; Kirsch LE
    AAPS PharmSciTech; 2018 Oct; 19(7):2801-2807. PubMed ID: 30120695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a microparticle-based dry powder inhalation formulation of ciprofloxacin hydrochloride applying the quality by design approach.
    Karimi K; Pallagi E; Szabó-Révész P; Csóka I; Ambrus R
    Drug Des Devel Ther; 2016; 10():3331-3343. PubMed ID: 27784991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comprehensive analysis and optimization of continuous twin-screw granulation processes via sequential experimentation strategy.
    Meng W; Rao KS; Snee RD; Ramachandran R; Muzzio FJ
    Int J Pharm; 2019 Feb; 556():349-362. PubMed ID: 30553003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality by design approach: application of artificial intelligence techniques of tablets manufactured by direct compression.
    Aksu B; Paradkar A; de Matas M; Ozer O; Güneri T; York P
    AAPS PharmSciTech; 2012 Dec; 13(4):1138-46. PubMed ID: 22956056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Critical Material Attributes (CMAs)-Particle Shape on Miniature Pharmaceutical Unit Operations.
    Azad MA; Capellades G; Wang AB; Klee DM; Hammersmith G; Rapp K; Brancazio D; Myerson AS
    AAPS PharmSciTech; 2021 Mar; 22(3):98. PubMed ID: 33709195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of wet granulation process with Plackett-Burman design--case study.
    Woyna-Orlewicz K; Jachowicz R
    Acta Pol Pharm; 2011; 68(5):725-33. PubMed ID: 21928718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An engineering study on the enhanced control and operation of continuous manufacturing of pharmaceutical tablets via roller compaction.
    Singh R; Ierapetritou M; Ramachandran R
    Int J Pharm; 2012 Nov; 438(1-2):307-26. PubMed ID: 22982489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality-by-design III: application of near-infrared spectroscopy to monitor roller compaction in-process and product quality attributes of immediate release tablets.
    Kona R; Fahmy RM; Claycamp G; Polli JE; Martinez M; Hoag SW
    AAPS PharmSciTech; 2015 Feb; 16(1):202-16. PubMed ID: 25319052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A cross-industry forum on benchmarking critical quality attribute identification and linkage to process characterization studies.
    Demmon S; Bhargava S; Ciolek D; Halley J; Jaya N; Joubert MK; Koepf E; Smith P; Trexler-Schmidt M; Tsai P
    Biologicals; 2020 Sep; 67():9-20. PubMed ID: 32665104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of quality by design (QbD) to formulation and processing of naproxen pellets by extrusion-spheronization.
    Wang J; Kan S; Chen T; Liu J
    Pharm Dev Technol; 2015 Mar; 20(2):246-56. PubMed ID: 25069591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving the content uniformity of a low-dose tablet formulation through roller compaction optimization.
    am Ende MT; Moses SK; Carella AJ; Gadkari RA; Graul TW; Otano AL; Timpano RJ
    Pharm Dev Technol; 2007; 12(4):391-404. PubMed ID: 17763144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement of a stability-indicating method by Quality-by-Design versus Quality-by-Testing: a case of a learning process.
    Hubert C; Lebrun P; Houari S; Ziemons E; Rozet E; Hubert P
    J Pharm Biomed Anal; 2014 Jan; 88():401-9. PubMed ID: 24176744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The study of the applicability of content uniformity and weight variation test--the state of commercial tablets and capsules in Japan.
    Katori N; Aoyagi N; Kojima S
    Chem Pharm Bull (Tokyo); 2001 Nov; 49(11):1412-9. PubMed ID: 11724231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.